Records containing: Systemic Lupus Erythematosus
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-11-21Effect of Telitacicept on Transitional Regulatory B Cells in Patients With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2023-11-18Treatment and Clinical Outcomes Among SLE Patients in Pregnancy: A Real World Study
-
CLINICAL_TRIALS study record update · 2023-11-18A Phase 1, Double-blind, Randomized, Placebo-controlled, Ascending Multiple-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous NKTR-358 in Patients With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2023-11-09Immune Ablation and Hematopoietic Stem Cell Support in Patients With Poor Prognostic Indicators and Systemic Lupus Erythematosus:A Phase II Study
-
CLINICAL_TRIALS study record update · 2023-11-07Anti-DFS70 Antibodies and it's Relationship With Systemic Lupus Erythematosus Manifestations
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-11-07Validation of a Mobile Phone Based on EPRO Tool in Subjects With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2023-10-30A PHASE 1, RANDOMIZED, MULTI-CENTER, DOUBLE-BLIND, SPONSOR OPEN, PLACEBO-CONTROLLED, SINGLE AND MULTIPLE DOSE-ESCALATION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF PF-06835375 IN SUBJECTS WITH SEROPOSITIVE SYSTEMIC LUPUS ERYTHEMATOSUS OR RHEUMATOID ARTHRITIS
-
CLINICAL_TRIALS study record update · 2023-10-27A Randomised, Double-blind, Placebo-controlled, Phase 2 Study Evaluating the Safety and Efficacy of SM934 in Adult Subjects With Active Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2023-10-10Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
-
CLINICAL_TRIALS study record update · 2023-10-10Periodontal Status in Patients With Chronic Skin Diseases: a Pilot Study
-
CLINICAL_TRIALS study record update · 2023-09-22A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Cenerimod in Subjects With Moderate to Severe Systemic Lupus Erythematosus (SLE)
-
CLINICAL_TRIALS study record update · 2023-09-21A Model to Early Predict the Response of Belimumab Treatment in the Patients With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2023-09-18Assessment of Anxiety, Depression, Sleep Quality and Quality of Life in Systemic Lupus Erythematosus Patients
-
CLINICAL_TRIALS study record update · 2023-09-14Utilizing Qualitative and Quantitative Methods to Understand a New Model of Type 1 and 2 Systemic Lupus Erythematosus (SLE)
-
CLINICAL_TRIALS study record update · 2023-09-13Activity and Nutrition Trial in Lupus to Energize and Renew
-
CLINICAL_TRIALS study record update · 2023-09-11Clinical Risk Assessment of Cognitive Function in Systemic Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2023-08-21Immunogenicity, Reactogenicity and Safety of 2 Doses of an Adjuvanted Herpes Zoster Subunit Vaccine in Patients With Systemic Lupus Erythematosus: a Randomized Clinical Trial.
-
CLINICAL_TRIALS study record update · 2023-08-03The Research Registry for Neonatal Lupus
-
CLINICAL_TRIALS study record update · 2023-07-19A Randomized, Double-blind, Placebo-controlled Phase 1b Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Multiple Ascending Subcutaneous Doses of Efavaleukin Alfa in Subjects With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2023-07-03A Randomized Controlled Trial Aimed at Exploring the Efficacy of Telitacicept in the Treatment of Systemic Lupus Erythematosus Patients With Refractory Thrombocytopenia
-
CLINICAL_TRIALS study record update · 2023-06-22Sequential Belimumab Followed by T-cell Based Therapy in the Treatment of Systemic Lupus Erythematosus (SUBTLE) - a Preliminary Proof-of-concept Mechanistic Study
-
CLINICAL_TRIALS study record update · 2023-06-12Anti KU Antibodies and Its Relationship With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2023-05-30Neuron-specific Humoral and Cellular Immune Correlates of Structural and Functional Brain Connectomics in Neuropsychiatric Lupus
-
CLINICAL_TRIALS study record update · 2023-05-16A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
-
CLINICAL_TRIALS study record update · 2023-05-15A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects With Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects With Active Cutaneous Lupus Erythematosus With or Without Systemic Manifestations